Pan-cancer analysis shows that TNFSF4 is a potential prognostic and immunotherapeutic biomarker for multiple cancer types including liver cancer
Abstract Background As a member of the tumor necrosis factor (TNF) superfamily, tumor necrosis factor superfamily member 4 (TNFSF4) is expressed on antigen-presenting cells and activated T cells by binding to its receptor TNFRSF4. However, tumorigenicity of TNFSF4 has not been studied in pan-cancer....
Saved in:
Main Authors: | Zhaoda Deng, Lincheng Li, Zihe Meng, Guineng Zeng, Rui Cao, Rong Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2025-01-01
|
Series: | BMC Cancer |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12885-025-13479-4 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pan-Cancer Analysis of the Prognostic and Immunotherapeutic Value of PDGFB
by: Bai Y, et al.
Published: (2025-01-01) -
Comprehensive multi-omics analysis showed that CDC6 is a potential prognostic and immunotherapy biomarker for multiple cancer types including HCC
by: Chenxuan Li, et al.
Published: (2025-03-01) -
ITGA4 as a potential prognostic and immunotherapeutic biomarker in human cancer and its clinical significance in gastric cancer: an integrated analysis and validation
by: Jiaxing Zhang, et al.
Published: (2025-02-01) -
A pan-cancer analysis: predictive role of ZNF32 in cancer prognosis and immunotherapy response
by: Minghan Li, et al.
Published: (2025-01-01) -
Comprehensive pan-cancer analysis reveals NTN1 as an immune infiltrate risk factor and its potential prognostic value in SKCM
by: Fuxiang Luan, et al.
Published: (2025-01-01)